Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-000929
Filing Date
2016-05-26
Accepted
2016-05-26 16:14:40
Documents
1
Period of Report
2016-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_3980.html 4  
1 PRIMARY DOCUMENT doc4_3980.xml 4 21949
  Complete submission text file 0001638599-16-000929.txt   23327
Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORMEDIX INC. 745 RT. 202-206, SUITE 303 BRIDGEWATER NJ 08807
Business Address
Duffy Matthew (Reporting) CIK: 0001535481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 161678322